Back to Search
Start Over
BioXcel Therapeutics Receives Permanent J-Code for IGALMItm (dexmedetomidine) Sublingual Film from Centers for Medicare & Medicaid Services
- Source :
- Plus Company Updates. October 30, 2023
- Publication Year :
- 2023
-
Abstract
- NEW HAVEN, Conn: BioXcel Therapeutics has issued the following news release: BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.772702315